Genewiz Competitors and Similar CompaniesClear all
Integrated DNA Technologies's competitors and similar companies include UCB, Verona Pharma and Fate Therapeutics.
 Integrated DNA Technologies Integrated DNA Technologies (IDT) is a company that develops, manufactures, and markets nucleic acid products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases. |  Fate Therapeutics Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics. | |
Founding Date | Founding Date 1987 | Founding Date 1928 | Founding Date N/A | Founding Date 2007 |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Coralville, US HQ Glen Waverley, AU Leuven, BE Shanghai, CN Tokyo, JP Hanam Si, KR Singapore, SG see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations London, GB HQ Cardiff, GB Raleigh, US | Locations San Diego, US HQ San Diego, US |
Employees | Employees 1,7351% decrease | Employees 9,052 | Employees 79 | Employees 17871% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 34.3 b | Valuation ($) 2.7 b | Valuation ($) 309.7 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) $42.3m (FY, 2024) | Revenue (est.) $6.6m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods $1.4m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €7.2b (FY, 2025) | Gross profit $40.9m (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income €1.6b (FY, 2025) | Net income ($173.2m) (FY, 2024) | Net income ($136.3m) (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries 100 (Apr, 2023) | Countries 35 (FY, 2019) | Countries N/A | Countries N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 11.5m | Total funding raised $ 330.2m |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyVerona Pharma
HQ
London, GB
Employees
79
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
View companyFate Therapeutics
HQ
San Diego, US
Employees
178
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
View company